Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,646.50
-4.00 (-0.24%)
Sep 10, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Prescription Drugs | 276.81B | Log In | Log In | Log In | Log In | Upgrade |
Prescription Drugs Growth | -1.50% | Log In | Log In | Log In | Log In | Upgrade |
Over-the-counter Drugs | 11.58B | Log In | Log In | Log In | Log In | Upgrade |
Over-the-counter Drugs Growth | 2.99% | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices | 9.75B | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices Growth | 25.47% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.87B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -3.06% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.87B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -3.06% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Other | 1.35B | Log In | Log In | Log In | Log In | Upgrade |
Japan | 165.31B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | -5.86% | Log In | Log In | Log In | Log In | Upgrade |
EMEA | 74.32B | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | 14.77% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 30.10B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 4.99% | Log In | Log In | Log In | Log In | Upgrade |
China | 28.93B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -3.12% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.35B | Log In | Log In | Log In | Log In | Upgrade |
Americas | - | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | - | Log In | Log In | Log In | Log In | Upgrade |